Search Results 881-890 of 14781 for anti-TNF drugs

1. Ombitasvir, Paritaprevir, And Ritonavir (Oral Route) Precautions - Mayo Clinic

   These medicines may also cause birth defects if the father is using it when his sexual partner becomes pregnant. Avoid pregnancy during treatment and within 6 ...

2. Ibuprofen And Pseudoephedrine (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Trastuzumab And Hyaluronidase-Oysk (Subcutaneous Route) Proper Use - Mayo Clinic

   Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and ...

4. Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   It is also used after an initial treatment plan to treat HER2-positive early breast cancer which has a high risk of occurring again.

5. Immune checkpoint-induced hypoparathyroidism: A case from the endocrine teaching clinics

   Immune checkpoint inhibitor (ICI) drugs have revolutionized cancer therapy ... He started a combination immunotherapy of ipilimumab (anti-CTLA-4) and nivolumab ( ...

6. Selinexor Treatment of Refractory Myeloma - Mayo Clinic

   ... anti-CD38 mAb, daratumumab. Refractory is defined as ≤ 25% response to therapy, or progression during therapy or progression within 60 days after ...

7. Levonorgestrel And Ethinyl Estradiol (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Alesse; Alesse-28; Altavera; Amethia ...

8. Mayo Clinic Comprehensive Cancer Center Research

   ... anti-PD-1 antibody blockade enhances anti-tumor activity in glioblastoma treatment; Demonstrating that intraperitoneal administration of measles virus-sodium ...

9. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma - Mayo Clinic

   Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent. Participating Mayo Clinic locations. Study statuses change often. Please contact ...

10. Paclitaxel (Intravenous Route) Precautions - Mayo Clinic

    Cancer medicines can cause diarrhea, nausea, or vomiting in most people, sometimes even after receiving medicines to prevent it. Ask your doctor or nurse about ...